Correlation Between Novo Nordisk and ArcelorMittal

Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and ArcelorMittal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and ArcelorMittal into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novo Nordisk AS and ArcelorMittal SA ADR, you can compare the effects of market volatilities on Novo Nordisk and ArcelorMittal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of ArcelorMittal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and ArcelorMittal.

Diversification Opportunities for Novo Nordisk and ArcelorMittal

-0.28

Correlation Coefficient

Novo Nordisk  ArcelorMittal

Very good diversification

The 3 months correlation between Novo and ArcelorMittal is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and ArcelorMittal SA ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArcelorMittal SA ADR and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with ArcelorMittal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArcelorMittal SA ADR has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and ArcelorMittal go up and down completely randomly.

Pair Corralation between Novo Nordisk and ArcelorMittal

Assuming the 90 days horizon Novo Nordisk AS is expected to generate 0.67 times more return on investment than ArcelorMittal. However, Novo Nordisk AS is 1.49 times less risky than ArcelorMittal. It trades about -0.07 of its potential returns per unit of risk. ArcelorMittal SA ADR is currently generating about -0.16 per unit of risk. If you would invest  12,940  in Novo Nordisk AS on January 26, 2024 and sell it today you would lose (260.00) from holding Novo Nordisk AS or give up 2.01% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Novo Nordisk AS  vs.  ArcelorMittal SA ADR

Novo Nordisk AS

Risk-Adjusted Performance

9 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Novo Nordisk AS are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Novo Nordisk reported solid returns over the last few months and may actually be approaching a breakup point.

ArcelorMittal SA ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ArcelorMittal SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Novo Nordisk and ArcelorMittal

The main advantage of trading using opposite Novo Nordisk and ArcelorMittal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, ArcelorMittal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArcelorMittal will offset losses from the drop in ArcelorMittal's long position.

The idea behind Novo Nordisk AS and ArcelorMittal SA ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.